DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment



Oncology Homepage

Computerized tissue imaging may predict who will benefit from chemotherapy NCI-funded trial to investigate this technology

New MR imaging technique doesn't require use of contrast agents Detects 98 percent of malignant breast lesions

Ultrasound with 'cheap' blood test improves early-stage liver cancer detection by 40 percent May become standard practice

FDA clears the Arterys Oncology AI suite Designed for liver MR and CT and lung CT

Tomo associated with fewer false positives than digital mammo, study finds To be presented at ARRS annual meeting

Congress freezes radiation treatment payment rates for free-standing clinics through 2019 ASTRO applauds

For this cancer, proton therapy is no better than IMRT For treating NSCLC, the cutting edge option may not yield better outcomes

Study finds PSMA PET/CT can identify early prostate cancer recurrence Already a standard in Europe

RaySearch to supply RayStation to first proton therapy center in India Set to begin treating patients in September 2018

New paper brings attention to heart disease risk associated with breast cancer treatment Especially affects those over 65

Precision medicine is having a big impact on breast cancer chemo decisions: study

by Lauren Dubinsky , Senior Reporter
While the concept of precision medicine still has a futuristic ring to it, researchers at the University of Michigan are showing how physicians in everyday practice can use biomarker tests to make significantly more personalized decisions regarding which breast cancer patients may require chemotherapy to ensure recurrence doesn't happen, and which patients are probably better off without.

"The idea of precision medicine is to give patients the treatments that are the most likely to help and avoid needless side effects," Christopher Friese, study author and professor at the University of Michigan School of Nursing, said in a statement.

Story Continues Below Advertisement

The (#1 Resource) for Medical Imaging and Peripherals. Call 1-949-273-8000

As a Master Distributor for major brands Barco, Philips, and Sony, we offer custom imaging solutions. With our renowned OEM Solutions and Service/Repair Center, Ampronix is a one-stop shop for HD Medical LCD Displays--Printers--Recorders--4K Cameras

The test is called the 21-gene recurrence score assay (RS) and it looks at 21 genes that are known to increase the risk of cancer recurrence. The goal is to avoid chemotherapy in patients who are at low risk because they most likely won’t benefit from it and to make sure that chemotherapy is recommended for women at high risk.

The researchers surveyed 3,880 women who were treated for breast cancer in 2013 and 2014 in California and Georgia. A total of 1,527 patients with early-stage breast cancer responded to the survey and 778 received the test.

They found that 47.2 percent of the patients with RS scores received a recommendation against chemotherapy and 40.6 percent received a recommendation for it. Those results correlated with the professional guideline recommendations.

However, they did find that about 13 percent of the patients whose lymph nodes were positive for breast cancer were given the test — even though there’s no evidence they would have benefitted from the test or the outcome.

The researchers evaluated registry and laboratory data and found that 60 percent of the patients accurately recalled receiving the test.

"This suggests that while precision medicine for breast cancer has left the station, we have left a few women behind," said Friese. "There's opportunity in the oncology community to improve how we explain to women the purpose of these tests, how to interpret the results, and what the results mean for their breast cancer treatment."

In addition, almost two-thirds thought the test was helpful in shifting their opinion for or against chemotherapy.

Oncology Homepage

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to, Inc. Copyright ©2001-2018, Inc.